Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals

Francesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, Pierluigi Bonfili, Mario Di Staso, Caterina Fardella, Lorella Polidoro, Carmela Ciccarelli, Claudio Festuccia, Vladimir M. Popov, Richard G. Pestell, Vincenzo Tombolini, Bianca Maria Zani

Mol Cancer Ther (2011) 10 (1): 159–168.

https://doi.org/10.1158/1535-7163.MCT-10-0631

Published: 10 January 2011

View article titled, MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells <em>In vitro</em> and <em>In vivo</em> by Downregulating Growth and DNA Repair Signals

Includes: Supplementary data

Journal Articles

MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma

Francesco Marampon, Gianluca Bossi, Carmela Ciccarelli, Agnese Di Rocco, Ada Sacchi, Richard G. Pestell, Bianca M. Zani

Mol Cancer Ther (2009) 8 (3): 543–551.

https://doi.org/10.1158/1535-7163.MCT-08-0570

Published: 13 March 2009

View article titled, MEK/ERK inhibitor U0126 affects <em>in vitro</em> and <em>in vivo</em> growth of embryonal rhabdomyosarcoma

Includes: Supplementary data

Journal Articles

Construction of a novel DNA decoy that inhibits the oncogenic β-catenin/T-cell factor pathway

Yosuke Seki, Hirofumi Yamamoto, Chew Yee Ngan, Masayoshi Yasui, Naruya Tomita, Kotaro Kitani, Ichiro Takemasa, Masataka Ikeda, Mitsugu Sekimoto, Nariaki Matsuura, Chris Albanese, Yasufumi Kaneda, Richard G. Pestell, Morito Monden

Mol Cancer Ther (2006) 5 (4): 985–994.

https://doi.org/10.1158/1535-7163.MCT-05-0388

Published: 28 April 2006

View article titled, Construction of a novel DNA decoy that inhibits the oncogenic β-catenin/T-cell factor pathway

Journal Articles

Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways

Kongming Wu, Chenguang Wang, Mark D’Amico, Richard J. Lee, Chris Albanese, Richard G. Pestell, Sridhar Mani

Mol Cancer Ther (2002) 1 (9): 695–706.

Published: 01 July 2002

View article titled, Flavopiridol and Trastuzumab Synergistically Inhibit Proliferation of Breast Cancer Cells: Association with Selective Cooperative Inhibition of Cyclin D1-dependent Kinase and Akt Signaling Pathways